Fasching PA, Schmatloch S, Hauke J, Rey J, et al. Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study. Clin Cancer Res 2025;31:1596-1604.
PMID: 39998850